生物活性 | |||
---|---|---|---|
描述 | Exarafenib (RAF/KIN_2787) is an oral, selective pan-RAF inhibitor effective against RAF-dependent cancers, covering all types of BRAF mutations. It inhibits MAPK signaling in RAF-dependent melanoma cell lines and exhibits anticancer properties[1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.92mL 0.38mL 0.19mL |
9.59mL 1.92mL 0.96mL |
19.17mL 3.83mL 1.92mL |
参考文献 |
---|
[2]WHO Drug Information. International Nonproprietary Names for Pharmaceutical |